Company: BIAF
Filing Date: 2025-09-30
Form Type: 424B4
Source: 0001493152-25-016338
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-30
Form: 424B4
Chunk 0
---
Filed Pursuant to Rule 424(b)(4)

Registration No. 333-290480

PROSPECTUS

<div align='center'>bioAffinity Technologies, Inc.

1,047,694Shares of Common Stock

874,067Pre-Funded Warrants to Purchase Shares of Common Stock

Up to 874,067 Shares of Common Stock Underlying the Pre-Funded Warrants</div>

We are offering 1,047,694 shares of our Common Stock, $0.007 par value per share (the “Common Stock”). The public offering price for each share of Common Stock is $2.50.

We are also offering to each purchaser whose purchase of shares of our Common Stock in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of the outstanding shares of Common Stock immediately following the consummation of this offering, the opportunity to purchase, if the purchaser so chooses, Pre-Funded Warrants to purchase shares of Common Stock, or the Pre-Funded Warrants, in lieu of shares of Common Stock. Each Pre-Funded Warrant will be exercisable for one share of our Common Stock and will be immediately exercisable and will expire when exercised in full. The purchase price of each Pre-Funded Warrant will equal the price per share of Common Stock being sold to the public, minus $0.007, and the exercise price of each Pre-Funded Warrant will be $0.007 per share. We are also registering the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants pursuant to this prospectus.

This offering will terminate on October 31, 2025, unless we decide to terminate the offering (which we may do at any time in our discretion) prior to that date. We will have one closing for all the securities purchased in this offering. The public offering price per share (or Pre-Funded Warrant) will be fixed for the duration of this offering.

Our Common Stock is listed on the Nasdaq Capital Market under the symbol “BIAF.” We have not applied, and do not intend to apply, to list the Pre-Funded Warrants on the Nasdaq Capital Market. On September 26, 2025, the closing price of our Common Stock on the Nasdaq Capital Market was $5.29 per share. The trading price of our Common Stock has been,